Loading
PDBj
メニューPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

1LWO

Crystal structure of rabbit muscle glycogen phosphorylase a in complex with a potential hypoglycaemic drug at 2.0 A resolution

1LWO の概要
エントリーDOI10.2210/pdb1lwo/pdb
関連するPDBエントリー1H5U 1LWN
分子名称glycogen phosphorylase, alpha-D-glucopyranose, PYRIDOXAL-5'-PHOSPHATE, ... (5 entities in total)
機能のキーワードtype 2 diabetes, glycogen phosphorylase, inhibitor, new allosteric site, transferase
由来する生物種Oryctolagus cuniculus (rabbit)
タンパク質・核酸の鎖数1
化学式量合計98242.38
構造登録者
Oikonomakos, N.G.,Chrysina, E.D.,Kosmopoulou, M.N.,Leonidas, D.D. (登録日: 2002-06-01, 公開日: 2002-06-19, 最終更新日: 2023-10-25)
主引用文献Oikonomakos, N.G.,Chrysina, E.D.,Kosmopoulou, M.N.,Leonidas, D.D.
Crystal structure of rabbit muscle glycogen phosphorylase a in complex with a potential hypoglycaemic drug at 2.0 A resolution
BIOCHEM.BIOPHYS.ACTA PROTEINS & PROTEOMICS, 1647:325-332, 2003
Cited by
PubMed Abstract: CP320626 has been identified as a potent inhibitor, synergistic with glucose, of human liver glycogen phosphorylase a (LGPa), a possible target for type 2 diabetes therapy. CP320626 is also a potent inhibitor of human muscle GPa. In order to elucidate the structural basis of the mechanism of CP320626 inhibition, the structures of T state rabbit muscle GPa (MGPa) in complex with glucose and in complex with both glucose and CP320626 were determined at 2.0 A resolution, and refined to crystallographic R values of 0.179 (R(free)=0.218) and 0.207 (R(free)=0.235), respectively. CP320626 binds at the new allosteric site, some 33 A from the catalytic site, where glucose binds. The binding of CP320626 to MGPa does not promote extensive conformational changes except for small shifts of the side chain atoms of residues R60, V64, and K191. Both CP320626 and glucose promote the less active T state, while structural comparisons of MGPa-glucose-CP320626 complex with LGPa complexed with a related compound (CP403700) and a glucose analogue inhibitor indicate that the residues of the new allosteric site, conserved in the two isozymes, show no significant differences in their positions.
PubMed: 12686153
DOI: 10.1016/S1570-9639(03)00085-2
主引用文献が同じPDBエントリー
実験手法
X-RAY DIFFRACTION (2 Å)
構造検証レポート
Validation report summary of 1lwo
検証レポート(詳細版)ダウンロードをダウンロード

252816

件を2026-04-29に公開中

PDB statisticsPDBj update infoContact PDBjnumon